Suppr超能文献

佛波酯在体内和体外对大鼠肝脏金属硫蛋白的诱导作用。

Phorbol ester induction of rat hepatic metallothionein in vivo and in vitro.

作者信息

Garrett S H, Xiong X, Arizono K, Brady F O

机构信息

Department of Biochemistry and Molecular Biology, University of South Dakota School of Medicine, Vermillion 57069.

出版信息

Int J Biochem. 1992 Oct;24(10):1669-76. doi: 10.1016/0020-711x(92)90186-5.

Abstract
  1. The induction of metallothionein (MT) protein by TPA (O-tetradecanoyl phorbol acetate), a protein kinase C activator, was demonstrated in vivo in rat liver and in vitro in rat hepatocytes in primary culture. In vivo half maximal induction at 25 hr was seen at 26 nmol TPA/kg body wt. Five- to seven-fold inductions were seen in vivo. De novo protein synthesis was required for this induction as demonstrated by cycloheximide inhibition of [35S]cysteine incorporation into MT protein. 2. TPA induction of MT protein in primary cultures of rat hepatocytes reached levels of 2.6-4.1-fold, as assessed by [35S]cysteine incorporation, 1.34-2.20-fold, as assessed by 109Cd binding in a metal displacement/HPLC assay, and 2.5-5-fold, as assessed by 109Cd binding in a metal displacement/Sephadex G-75 Superfine assay. 3. The induction of MT mRNA by TPA was demonstrated in vivo in rat liver and in vitro in 2 rat hepatoma cell lines, EC3 and 2M. MT mRNA was quantitated using dot blot and Northern gel assays. In vivo TPA induced hepatic MT mRNA 2.36-5.88-fold (dot blot) and 7.4-22-fold (Northern gels). In vitro TPA induced MT mRNA 1.71-15.26-fold in EC3 cells and 2.23-8.43-fold in 2M cells. MT mRNA was 0.54 kb, and alpha-tubulin mRNA was 1.62 kb in size on Northern gels. 4. TPA induction of MT protein and mRNA in vivo and in vitro is rapid and persistent and occurs at low concentrations. The 2 rat hepatoma cell lines provide a useful system in which to study MT induction in vitro without confounding secondary effects which can occur in vivo.
摘要
  1. 蛋白激酶C激活剂佛波酯(TPA,即十四酰佛波醇乙酯)可在大鼠肝脏中诱导金属硫蛋白(MT)的体内表达,并在原代培养的大鼠肝细胞中诱导其体外表达。在体内,25小时时,26 nmol TPA/千克体重可实现半数最大诱导。体内诱导倍数可达5至7倍。放线菌酮抑制[35S]半胱氨酸掺入MT蛋白的实验表明,这种诱导需要从头合成蛋白质。2. 通过[35S]半胱氨酸掺入法评估,TPA在大鼠肝细胞原代培养物中诱导MT蛋白的水平达2.6至4.1倍;通过金属置换/HPLC法中的109Cd结合评估,诱导水平为1.34至2.20倍;通过金属置换/葡聚糖凝胶G-75超细柱法中的109Cd结合评估,诱导水平为2.5至5倍。3. TPA可在大鼠肝脏中诱导MT mRNA的体内表达,并在两种大鼠肝癌细胞系EC3和2M中诱导其体外表达。使用斑点印迹法和Northern凝胶分析法对MT mRNA进行定量。在体内,TPA诱导肝脏MT mRNA的倍数为2.36至5.88倍(斑点印迹法)和7.4至22倍(Northern凝胶法)。在体外,TPA在EC3细胞中诱导MT mRNA的倍数为1.71至15.26倍,在2M细胞中为2.23至8.43倍。在Northern凝胶上,MT mRNA大小为0.54 kb,α-微管蛋白mRNA大小为1.62 kb。4. TPA在体内和体外诱导MT蛋白和mRNA的过程迅速且持久,并且在低浓度下即可发生。这两种大鼠肝癌细胞系为体外研究MT诱导提供了一个有用的系统,可避免体内可能出现的混淆性继发效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验